| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $24K | — | — |
| SG&A Expense | $265K | +23.9% | -37.3% |
| Operating Income | -$453K | +7.1% | -172.7% |
| Net Income | -$453K | +7.1% | +27.3% |
| EPS (Basic) | $0.00 | — | +100.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $92K | +814.3% | +5091.6% |
| Current Assets | $113K | +458.1% | +697.9% |
| Total Assets | $231K | +59.2% | +27.8% |
| Current Liabilities | $2.5M | +18.5% | +27.0% |
| Total Liabilities | $2.5M | +18.5% | +27.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$612K | -154.6% | — |
| Financing Cash Flow | $623K | +267.8% | — |
| -$2.3M |
| -15.5% |
| -26.9% |